SAN FRANCISCO, April 12, 2024 (GLOBE NEWSWIRE) — American Shared Hospital Companies (NYSE American: AMS) (the “Firm”), a number one supplier of turnkey expertise options for stereotactic radiosurgery and superior radiation remedy gear and providers, at the moment publicizes the sudden passing of its Chief Government Officer, Peter Gaccione.
Ray Stachowiak, Government Chairman of American Shared Hospital Companies, mentioned, “On behalf of my colleagues at AMS, we’re deeply saddened by the sudden passing of Peter Gaccione and we prolong our honest sympathies to his household. Peter’s enthusiasm, integrity, and empowering management fashion have formed the group over the previous 18 months, and his large contribution to AMS won’t be forgotten.”
Mr. Gaccione was appointed CEO at AMS in March 2023 after serving briefly as the corporate’s Chief Working Officer. He introduced 40 years of expertise within the world Radiation Oncology and Imaging enterprise to the position, together with time spent as President and a Member of the Government Administration Board of Myocardial Options Inc., a medical expertise firm within the cardiology and cardio-oncology discipline, the place he led the product commercialization, gross sales, advertising improvement, and medical groups.
Mr. Gaccione additionally served at Elekta AB, a supplier of precision radiation oncology therapy programs, brachytherapy, neuroscience, and software program options, from 1997 to 2020, culminating in his promotion to the place of President and Chief Government Officer of Elekta Inc. and Elekta Medical S.A. de C.V. (Mexico), in addition to Government Vice President of Elekta North and Latin America Areas and a Member of the Elekta AB International Government Administration staff from June 2017 to February 2020.
About American Shared Hospital Companies (NYSE American: AMS)
American Shared Hospital Companies (ASHS) is a number one supplier of inventive monetary and turnkey options to Most cancers Therapy Facilities, hospitals, and huge most cancers networks worldwide. The corporate works intently with all main world Authentic Tools Producers (OEMs) that present forefront medical therapy programs and software program to deal with most cancers utilizing Radiation Remedy and Radiosurgery. The corporate is vendor agnostic and offers monetary assist for a variety of merchandise together with MR Guided Radiation Remedy Linacs, Superior Digital Linear Accelerators, Proton Beam Remedy Techniques, Brachytherapy programs and suites, and thru the Firm’s subsidiary, GK Financing LLC., the Leksell Gamma Knife product and providers. For extra info, please go to www.ashs.com.
Protected Harbor Assertion
This press launch could also be deemed to comprise sure forward-looking statements with respect to the monetary situation, outcomes of operations and future plans of American Shared Hospital Companies (together with statements relating to the anticipated continued development of the Firm and the enlargement of the Firm’s Gamma Knife, proton remedy and MR/LINAC enterprise, which contain dangers and uncertainties together with, however not restricted to, the dangers of financial and market situations, the dangers of variability of monetary outcomes between quarters, the dangers of the Gamma Knife and proton remedy companies, the dangers of adjustments to CMS reimbursement charges or reimbursement methodology, the dangers of the timing, financing, and operations of the Firm’s Gamma Knife, proton remedy, and MR/LINAC companies, the chance of increasing inside or into new markets, the chance that the combination or continued operation of acquired companies may adversely have an effect on monetary outcomes and the chance that present and future acquisitions could negatively have an effect on the Firm’s monetary place. Additional info on potential components that would have an effect on the monetary situation, outcomes of operations and future plans of American Shared Hospital Companies is included within the filings of the Firm with the Securities and Change Fee, together with the Firm’s Annual Report on Type 10-Ok for the 12 months ended December 31, 2023, and the definitive Proxy Assertion for the Annual Assembly of Shareholders that was held on June 20, 2023.
Contacts:
American Shared Hospital Companies
Ray Stachowiak
Government Chairman
[email protected]
Investor Relations
PCG Advisory
Jeff Ramson
[email protected]
The put up American Shared Hospital Companies Proclaims the Sudden Passing of CEO, Peter Gaccione – TipRanks Monetary Weblog appeared first on Make investments.